Incidence, screening, and management of
Publication/Presentation Date
9-18-2025
Abstract
Liver transplantation (LT) is the definitive treatment for end-stage liver disease, acute liver failure, and liver cancer. Although advancements in surgical techniques, postoperative care, and immunosuppressive therapies have significantly improved outcomes, the long-term use of immunosuppression has increased the risk of complications, including infections, cardiovascular disease, and cancer. Among these,
Volume
15
Issue
3
First Page
101046
Last Page
101046
ISSN
2220-3230
Published In/Presented At
Singh, A., Singh, C., Dhaliwal, A., Singh, N., Kumar, V., Sohal, A., & Schneider, J. (2025). Incidence, screening, and management of de novo malignancies in liver transplant patients: A review. World journal of transplantation, 15(3), 101046. https://doi.org/10.5500/wjt.v15.i3.101046
Disciplines
Medicine and Health Sciences
PubMedID
40881759
Department(s)
Fellows and Residents
Document Type
Article